A detailed history of Congress Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Congress Wealth Management LLC holds 47,709 shares of LLY stock, worth $35.8 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
47,709
Previous 43,715 9.14%
Holding current value
$35.8 Million
Previous $39.6 Million 6.79%
% of portfolio
0.59%
Previous 0.65%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $3.08 Million - $3.83 Million
3,994 Added 9.14%
47,709 $42.3 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $3.73 Million - $4.67 Million
5,139 Added 13.32%
43,715 $39.6 Million
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $1.31 Million - $1.75 Million
2,212 Added 6.08%
38,576 $30 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $1.98 Million - $2.34 Million
3,776 Added 11.59%
36,364 $21.2 Million
Q3 2023

Oct 30, 2023

SELL
$434.7 - $599.3 $1.97 Million - $2.71 Million
-4,527 Reduced 12.2%
32,588 $17.5 Million
Q2 2023

Jul 13, 2023

BUY
$350.74 - $468.98 $48,402 - $64,719
138 Added 0.37%
37,115 $17.4 Million
Q1 2023

Apr 14, 2023

SELL
$310.63 - $364.82 $23,607 - $27,726
-76 Reduced 0.21%
36,977 $12.7 Million
Q4 2022

Feb 02, 2023

SELL
$321.55 - $374.67 $99,680 - $116,147
-310 Reduced 0.83%
37,053 $13.6 Million
Q3 2022

Nov 08, 2022

BUY
$296.48 - $337.87 $355,776 - $405,444
1,200 Added 3.32%
37,363 $12.1 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $15,608 - $18,327
56 Added 0.16%
36,163 $11.7 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $7.96 Million - $9.9 Million
33,935 Added 1562.38%
36,107 $10.3 Million
Q4 2021

Feb 04, 2022

BUY
$224.85 - $279.04 $488,374 - $606,074
2,172 New
2,172 $600,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Congress Wealth Management LLC Portfolio

Follow Congress Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Congress Wealth Management LLC with notifications on news.